Original
Eficacia a 2 años de tocilizumab en pacientes con artritis reumatoide activa en la práctica clínica habitual
Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice
Irene Notario Ferreira
, Miguel Angel Ferrer González, Pilar Morales Garrido, Alfonso González Utrilla, Antonio García Sanchez, María José Soto Pino, Evelyn Suero Rosario, Cristina Caro Hernández, Isabel Añón Oñate, Lorena Pérez Albaladejo, Rafael Cáliz Cáliz
Autor para correspondencia
Unidad de Gestión Clínica de Reumatología, Complejo Hospitalario Universitario de Granada, Granada, España
Leído
13385
Vecesse ha leído el artículo
3737
Total PDF
9648
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 22 | 28 |
| 2025 5 | 147 | 44 | 191 |
| 2025 4 | 123 | 38 | 161 |
| 2025 3 | 143 | 37 | 180 |
| 2025 2 | 123 | 41 | 164 |
| 2025 1 | 144 | 63 | 207 |
| 2024 12 | 114 | 27 | 141 |
| 2024 11 | 158 | 65 | 223 |
| 2024 10 | 56 | 43 | 99 |
| 2024 9 | 82 | 17 | 99 |
| 2024 8 | 116 | 32 | 148 |
| 2024 7 | 103 | 41 | 144 |
| 2024 6 | 148 | 40 | 188 |
| 2024 5 | 122 | 24 | 146 |
| 2024 4 | 130 | 36 | 166 |
| 2024 3 | 113 | 29 | 142 |
| 2024 2 | 72 | 22 | 94 |
| 2024 1 | 87 | 28 | 115 |
| 2023 12 | 125 | 19 | 144 |
| 2023 11 | 99 | 36 | 135 |
| 2023 10 | 162 | 31 | 193 |
| 2023 9 | 174 | 37 | 211 |
| 2023 8 | 83 | 10 | 93 |
| 2023 7 | 103 | 38 | 141 |
| 2023 6 | 92 | 33 | 125 |
| 2023 5 | 82 | 37 | 119 |
| 2023 4 | 62 | 22 | 84 |
| 2023 3 | 126 | 40 | 166 |
| 2023 2 | 123 | 38 | 161 |
| 2022 1 | 78 | 27 | 105 |
| 2022 12 | 96 | 51 | 147 |
| 2022 11 | 108 | 53 | 161 |
| 2022 10 | 107 | 51 | 158 |
| 2022 9 | 85 | 39 | 124 |
| 2022 8 | 118 | 48 | 166 |
| 2022 7 | 107 | 44 | 151 |
| 2022 6 | 148 | 35 | 183 |
| 2022 5 | 99 | 61 | 160 |
| 2022 4 | 136 | 52 | 188 |
| 2022 3 | 107 | 71 | 178 |
| 2022 2 | 122 | 53 | 175 |
| 2021 1 | 155 | 55 | 210 |
| 2021 12 | 164 | 59 | 223 |
| 2021 11 | 110 | 53 | 163 |
| 2021 10 | 79 | 50 | 129 |
| 2021 9 | 75 | 53 | 128 |
| 2021 8 | 46 | 47 | 93 |
| 2021 7 | 64 | 31 | 95 |
| 2021 6 | 101 | 33 | 134 |
| 2021 5 | 169 | 67 | 236 |
| 2021 4 | 176 | 106 | 282 |
| 2021 3 | 146 | 40 | 186 |
| 2021 2 | 98 | 24 | 122 |
| 2020 1 | 86 | 35 | 121 |
| 2020 12 | 56 | 20 | 76 |
| 2020 11 | 62 | 24 | 86 |
| 2020 10 | 63 | 24 | 87 |
| 2020 9 | 85 | 53 | 138 |
| 2020 8 | 106 | 51 | 157 |
| 2020 7 | 89 | 24 | 113 |
| 2020 6 | 83 | 25 | 108 |
| 2020 5 | 98 | 29 | 127 |
| 2020 4 | 86 | 29 | 115 |
| 2020 3 | 168 | 30 | 198 |
| 2020 2 | 80 | 31 | 111 |
| 2020 1 | 74 | 34 | 108 |
| 2019 12 | 62 | 39 | 101 |
| 2019 11 | 68 | 29 | 97 |
| 2019 10 | 58 | 15 | 73 |
| 2019 9 | 62 | 24 | 86 |
| 2019 8 | 83 | 17 | 100 |
| 2019 7 | 77 | 27 | 104 |
| 2019 6 | 62 | 31 | 93 |
| 2019 5 | 143 | 65 | 208 |
| 2019 4 | 77 | 53 | 130 |
| 2019 3 | 63 | 42 | 105 |
| 2019 2 | 48 | 23 | 71 |
| 2019 1 | 74 | 37 | 111 |
| 2018 12 | 112 | 68 | 180 |
| 2018 11 | 126 | 14 | 140 |
| 2018 10 | 79 | 15 | 94 |
| 2018 9 | 61 | 14 | 75 |
| 2018 8 | 43 | 8 | 51 |
| 2018 7 | 31 | 6 | 37 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 5 | 0 | 5 |
| 2018 4 | 60 | 15 | 75 |
| 2018 3 | 75 | 20 | 95 |
| 2018 2 | 72 | 6 | 78 |
| 2018 1 | 47 | 9 | 56 |
| 2017 12 | 51 | 12 | 63 |
| 2017 11 | 64 | 10 | 74 |
| 2017 10 | 73 | 20 | 93 |
| 2017 9 | 41 | 16 | 57 |
| 2017 8 | 56 | 22 | 78 |
| 2017 7 | 56 | 24 | 80 |
| 2017 6 | 76 | 47 | 123 |
| 2017 5 | 92 | 45 | 137 |
| 2017 4 | 325 | 67 | 392 |
| 2017 3 | 94 | 37 | 131 |
| 2017 2 | 2 | 25 | 27 |
| 2016 1 | 0 | 18 | 18 |
| 2016 12 | 0 | 37 | 37 |
| 2016 11 | 0 | 30 | 30 |
| 2016 10 | 0 | 48 | 48 |
| 2016 9 | 22 | 40 | 62 |
| 2016 8 | 36 | 24 | 60 |
| 2016 7 | 24 | 35 | 59 |
Mostrar todo
